This article is more than 5 years old. Information may no longer be current.

Antibiotic-steroid combination drug safe in preliminary results of phase 1 trial

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

ALAMEDA, Calif.— InSite Vision announced positive preliminary safety results from a phase 1 trial of its combination antibiotic-corticosteroid eye drop AzaSite Plus.

In the trial, 46 patients received either AzaSite Plus or placebo twice daily for 14 days, according to a press release from the company. The drug was well tolerated with no serious adverse events. Ocular side effects and IOP were similar between the two groups, according to the release.